These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28823823)

  • 21. Antibodies against Wnt receptor of muscle-specific tyrosine kinase in myasthenia gravis.
    Takamori M; Nakamura T; Motomura M
    J Neuroimmunol; 2013 Jan; 254(1-2):183-6. PubMed ID: 22999188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-MuSK Positive Myasthenia Gravis with Anti-Lrp4 and Anti-titin Antibodies.
    Yamashita R; Shimizu M; Baba K; Beck G; Kinoshita M; Okuno T; Higuchi O; Mochizuki H
    Intern Med; 2021 Jan; 60(1):137-140. PubMed ID: 32830177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic and clinical classification of autoimmune myasthenia gravis.
    Berrih-Aknin S; Frenkian-Cuvelier M; Eymard B
    J Autoimmun; 2014; 48-49():143-8. PubMed ID: 24530233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introducing Autoimmunity at the Synapse by a Novel Animal Model of Experimental Autoimmune Myasthenia Gravis.
    Wang J; Xiao Y; Zhang K; Luo B; Shen C
    Neuroscience; 2018 Mar; 374():264-270. PubMed ID: 29421431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort.
    Huda S; Woodhall MR; Vincent A; Heckmann JM
    Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.
    Higuchi O; Hamuro J; Motomura M; Yamanashi Y
    Ann Neurol; 2011 Feb; 69(2):418-22. PubMed ID: 21387385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myasthenia gravis and autoantibodies: Pathophysiology of the different subtypes].
    Berrih-Aknin S; Le Panse R
    Rev Med Interne; 2014 Jul; 35(7):413-20. PubMed ID: 24156976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Novel autoantibodies in myasthenia gravis].
    Nagaishi A; Sakai W; Motomura M
    Nihon Rinsho; 2013 May; 71(5):876-80. PubMed ID: 23777098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis.
    Yu Z; Zhang M; Jing H; Chen P; Cao R; Pan J; Luo B; Yu Y; Quarles BM; Xiong W; Rivner MH; Mei L
    Neurology; 2021 Sep; 97(10):e975-e987. PubMed ID: 34233932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-agrin autoantibodies in myasthenia gravis.
    Gasperi C; Melms A; Schoser B; Zhang Y; Meltoranta J; Risson V; Schaeffer L; Schalke B; Kröger S
    Neurology; 2014 Jun; 82(22):1976-83. PubMed ID: 24793185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical analysis of Chinese anti-low-density-lipoprotein-receptor-associated protein 4 antibodies in patients with myasthenia gravis.
    Li M; Han J; Zhang Y; Lv J; Zhang J; Zhao X; Ren L; Fang H; Yang J; Zhang Y; Cui X; Zhang Q; Li Q; Du Y; Gao F
    Eur J Neurol; 2019 Oct; 26(10):1296-e84. PubMed ID: 31050101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Change of voltage-gated sodium channel repertoire in skeletal muscle of a MuSK myasthenia gravis mouse model.
    Butenko O; Jensen SM; Fillié-Grijpma YE; Verpalen R; Verschuuren JJ; van der Maarel SM; Huijbers MG; Plomp JJ
    Eur J Neurosci; 2024 Jun; 59(12):3292-3308. PubMed ID: 38650308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcoidosis in a case of MuSK-positive myasthenia gravis.
    Spengos K; Vassilopoulou S; Christou Y; Manta P
    Neuromuscul Disord; 2008 Nov; 18(11):890-1. PubMed ID: 18815037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double seronegative myasthenia gravis with anti-LRP 4 antibodies.
    Zouvelou V; Zisimopoulou P; Rentzos M; Karandreas N; Evangelakou P; Stamboulis E; Tzartos SJ
    Neuromuscul Disord; 2013 Jul; 23(7):568-70. PubMed ID: 23768983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired Synaptic Development, Maintenance, and Neuromuscular Transmission in LRP4-Related Myasthenia.
    Selcen D; Ohkawara B; Shen XM; McEvoy K; Ohno K; Engel AG
    JAMA Neurol; 2015 Aug; 72(8):889-96. PubMed ID: 26052878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK.
    Küçükerden M; Huda R; Tüzün E; Yılmaz A; Skriapa L; Trakas N; Strait RT; Finkelman FD; Kabadayı S; Zisimopoulou P; Tzartos S; Christadoss P
    J Neuroimmunol; 2016 Jun; 295-296():84-92. PubMed ID: 27235354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice.
    Yan M; Liu Z; Fei E; Chen W; Lai X; Luo B; Chen P; Jing H; Pan JX; Rivner MH; Xiong WC; Mei L
    Neuroscience; 2018 Mar; 373():113-121. PubMed ID: 29339325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
    Reddel SW; Morsch M; Phillips WD
    Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sorting nexin 17 increases low-density lipoprotein receptor-related protein 4 membrane expression: A novel mechanism of acetylcholine receptor aggregation in myasthenia gravis.
    He X; Zhou S; Ji Y; Zhang Y; Lv J; Quan S; Zhang J; Zhao X; Cui W; Li W; Liu P; Zhang L; Shen T; Fang H; Yang J; Zhang Y; Cui X; Zhang Q; Gao F
    Front Immunol; 2022; 13():916098. PubMed ID: 36311763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional Signature of LRP4 Antibodies in Myasthenia Gravis.
    Chuquisana O; Stascheit F; Keller CW; Pučić-Baković M; Patenaude AM; Lauc G; Tzartos S; Wiendl H; Willcox N; Meisel A; Lünemann JD
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200220. PubMed ID: 38507656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.